Supreme Court Rebuffs Roundup Appeal, Leaving $25M Verdict Intact

 The U.S. Supreme Court has declined to hear Bayer AG's appeal of a lower court verdict over its Roundup weedkiller, leaving intact a $25 million judgment for a man who claimed the product gave him cancer. The German conglomerate, which inherited thousands of liability claims over Roundup when it acquired the Monsanto Co. in 2018, has set aside more than $4.5 billion to litigate the 30,000 or so remaining cases. Bayer, which paused settlement talks in those cases as it awaited the Supreme Court decision, is now likely to seek to quickly resolve those claims. The company had asked the high court to overturn the verdict in a lawsuit filed by California resident Edwin Hardeman, who alleged that Roundup should have included warnings that glyphosate, the herbicide's active ingredient, is a possible human carcinogen.
Joe Miller, Financial Times 6/21/2022